ANNOUNCEMENT 30 Nov 2012

In November 2012, the government of Brazil announced a change in import tariff quotas.

NUMBER OF INTERVENTIONS

1

  • 0 harmful
  • 0 neutral
  • 1 liberalising

SOURCE



Camex press release of 3 December 2012 (in Portuguese): http://www.camex.gov.br/noticias/ler/item/273
Camex resolution no. 85 of 30 November 2012 (in Portuguese): http://www.in.gov.br/visualiza/index.jsp?jornal=1&pagina=10&data=03/12/2012
Amended version of Camex resolution no. 85 of 30 November 2012 (in Portuguese): http://www.camex.gov.br/legislacao/interna/id/1007


Inception date: 03 Dec 2012 | Removal date: 03 Dec 2013
Still in force

Import tariff quota

On 30 November 2012, the Brazilian Foreign Trade Council (Camex) introduced tariff-rate quotas on caprolactam and various hemoderivatives:

  • The tariff for 6-hexanolactam (epsilon-caprolactam, NCM 2933.71.0) fell from 12% to 2% and is limited to 26.000 tons.
  • The tariff for human serum albumin (NCM 3002.10.37), a hemoderivative, has been reduced from 4% to 2% and is limited to 360.000 bottles of 10 grams each.
  • The tariff on factor VIII concentrate (NCM3002.10.39) has been reduced from 2% to 0% and is limited to 34.500 bottles of 500 international .

Camex resolution 85/12 took effect on 3 December 2012 and stays in force for a period of 180 days.
 
On 21 December 2012, Camex resolution no. 95/12 excluded human serum albumin from resolution no. 85/12.
 
On 31 May 2013, Camex resolution no. 37/13 revoked the tariff on factor VIII concentrate. On the same date, Camex resolution 38/13 prolonged the tariff reduction on 6-hexanolactam stipulated in Camex resolution no. 85/12 until 3 December 2013.
 
 
 
 

AFFECTED SECTORS